Celularity Newsroom

Celularity's Strategic Partner Announces Groundbreaking For Stem Cell & Regenerative Medicine Center In Asia Pacific

BenzingaNov 20 21:39

Celularity Shares Are Trading Higher. The Nasdaq Listing Qualifications Hearings Panel Has Cancelled the Previously Scheduled Hearing Regarding the Company's Non-compliance.

BenzingaNov 19 02:00

Celularity Inc. Announces Resolution of Nasdaq Listing Compliance Matter

GlobeNewswireNov 18 21:30

Sector Update: Health Care Stocks Rise Late Afternoon

MT NewswiresNov 8 04:58

Celularity CELU Increased Sales Guidance; Ensysce ENSC NASDAQ Extension

BioPharmCatalystNov 8 04:21

Top Midday Gainers

MT NewswiresNov 8 02:58

Celularity Shares Halted To The Upside; Stock Now Up 161.38%

BenzingaNov 8 02:24

10-Q: Q2 2024 Earnings Report

SECNov 8 00:49 · Announcements

12 Health Care Stocks Moving In Thursday's Intraday Session

BenzingaNov 8 00:31

Express News | Celularity Raises Full Year 2024 Guidance as Expected Net Sales Through October Reach $44.4 Million

BreakingsNov 7 21:00

Press Release: Celularity Raises Full Year 2024 Guidance as Expected Net Sales Through October Reach $44.4 Million

Dow JonesNov 7 21:00

Express News | Celularity : Intend to File Form 10-Q for Q2 2024 Within Coming Weeks

BreakingsOct 22 20:35

Celularity Provides Corporate Update; Says The Acquisition Of Rebound Adds To Our Portfolio Of Placental-Derived Advanced Biomaterial Products, Sales Of Which Through The First Half Of 2024 Were In Excess Of $24M; Guidance Of Expected Combined Net...

BenzingaOct 22 20:33

Express News | Celularity Provides Corporate Update

BreakingsOct 22 20:30

Sector Update: Health Care Stocks Fall Late Afternoon

MT NewswiresOct 22 04:01

Celularity Inc. Receives Notice From Nasdaq; Confirms Intention to File an Appeal

GlobeNewswireOct 19 06:00

10-Q: Q1 2024 Earnings Report

SECOct 17 05:28 · Announcements

Press Release: Celularity Expands Advanced Biomaterial Product Commercial Portfolio With Acquisition of Rebound(TM) Product From Sequence LifeScience, Inc.

Dow JonesOct 17 05:15

Express News | Celularity Expands Advanced Biomaterial Product Commercial Portfolio With Acquisition of Rebound™ Product From Sequence Lifescience, Inc.

BreakingsOct 17 05:15

Stem Cell Umbilical Cord Blood Market Report 2024, With Profiles of Cryo-Cell, Cordlife, ViaCord, CryoHoldco, LifeCell, StemCyte, Celularity Cryo-Save and Vita 34

Yahoo FinanceOct 8 16:33